The treatment of giardiasis in children: Single-dose tinidazole compared with 3 days of nitazoxanide

Annals of Tropical Medicine and Parasitology

Volumn 102, Issue 3, 2008, Pages 199-207

  Escobedo, A A ^a   Alvarez, G ^b   Gonzalez M E ^c   Almirall, P ^d   Canete R ^e   Cimerman, S ^f   Ruiz, A ^d   Perez R ^c  

^a Department of Microbiology   (Cuba)

^b Technical College of Health   (Cuba)

^c Gastro enterology Institute   (Cuba)

^d INSTITUTO DE MEDICINA TROPICAL PEDRO KOURÍ   (Cuba)

^e Provincial Centre of Hygiene Epidemiology and Microbiology   (Cuba)

^f INSTITUTO DE INFECTOLOGIA EMÍLIO RIBAS   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

DAXON; NITAZOXANIDE; TINIDAZOLE;

ABDOMINAL PAIN; ADOLESCENT; ARTICLE; BITTER TASTE; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DRUG EFFICACY; DRUG SAFETY; FECES ANALYSIS; FEMALE; FOLLOW UP; GIARDIA LAMBLIA; GIARDIASIS; HEADACHE; HUMAN; MAJOR CLINICAL STUDY; MALE; RANDOMIZED CONTROLLED TRIAL; RASH; SIDE EFFECT; SINGLE DRUG DOSE; TREATMENT RESPONSE; URINE COLOR;

ABDOMINAL PAIN; ADOLESCENT; ANTIPARASITIC AGENTS; CHILD; CHILD, PRESCHOOL; CUBA; DIARRHEA; FECES; FEMALE; GIARDIASIS; HUMANS; THIAZOLES; TINIDAZOLE; TREATMENT OUTCOME;

GIARDIA INTESTINALIS; PROTOZOA;

EID: 44449096542     PISSN: 00034983     EISSN: None     Source Type: Journal    
DOI: 10.1179/136485908X267894     Document Type: Article

References (36)

1. Abaza, H., El-Zayadi, A., Kabil, S. M. & Rizk, H. (1998). Nitazoxanide in the treatment of patients with intestinal protozoan and helminthic infections: a report on 546 patients in Egypt. Current Therapeutic Research, 59, 116-121.
2. Abboud, P., Lemee, V., Gargala, G., Brasseur, P., Ballet, J. J., Borsa-Lebas, F., Caron, F. & Favennec, L. (2001). Successful treatment of metronidazole-and albendazole-resistant giardiasis with nitazoxanide in a patient with acquired immunodeficiency syndrome. Clinical Infectious Diseases, 32, 1792-1794.
3. Adagu, I. S., Nolder, D., Warhurst, D. C. & Rossignol, J. F. (2002). In vitro activity of nitazoxanide and related compounds against isolates of Giardia intestinalis, Entamoeba histolytica and Trichomonas vaginalis. Journal of Antimicrobial Chemotherapy, 49, 103-111.
4. Adam, R. D. (2001). Biology of Giardia lamblia. Clinical Microbiology Reviews, 14, 447-476.
5. Armitage, P. & Berry, G. (1987). Statistical Methods in Medical Research, 2nd Edn. Oxford, U.K.: Blackwell Scientific.
6. Bernal-Redondo, R., Martinez-Mendez, L. G., Mendoza-Chavez, A., Velasco-Perales, D. & Chavez-Munguia, B. (2004). Evaluation of the in vitro effect of albendazole, metronidazole and nitazoxanide on viability and structure of Giardia lamblia cysts. Journal of Submicroscopic Cytology and Pathology, 36, 241-245.
7. Bobak, D. A. (2006). Use of nitazoxanide for gastrointestinal tract infections: treatment of protozoan parasitic infection and beyond. Current Infectious Disease Reports, 8, 91-95.
8. Cañete, R., Escobedo, A. A., González, M. E., Almirall, P. & Cantelar, N. (2006). A randomised, controlled, open-label trial of a single day of mebendazole versus a single dose of tinidazole in the treatment of giardiasis in children. Current Medical Research and Opinion, 22, 2131-2138.
9. Cedillo-Rivera, R., Chavez, B., González-Robles, A., Tapia, A. & Yepez-Mulia, L. (2002). In vitro effect of nitazoxanide against Entamoeba histolytica, Giardia intestinalis, and Trichomonas vaginalis trophozoites. Journal of Eukaryotic Microbiology, 49, 201-208.
10. Cimerman, S., Ladeira, M. C. T. & Iuliano, W. A. (2003). Blastocystosis: nitazoxanide as a new therapeutic option. Revista da Sociedade Brasileira de Medicina Tropical, 36, 415-417.
11. Cohen, S. A. (2005). Use of nitazoxanide as a new therapeutic option for persistent diarrhoea: a pediatric perspective. Current Medical Research and Opinion, 21, 999-1004.
12. Davila-Gutierrez, C. E., Vasquez, C., Trujillo-Hernandez, B. & Huerta, M. (2002). Nitazoxanide compared with quinfamide and mebendazole in the treatment of helminthic infections and intestinal protozoa in children. American Journal of Tropical Medicine and Hygiene, 66, 251-254.
13. Diaz, E., Mondragon, J., Ramirez, E. & Bernal, R. (2003). Epidemiology and control of intestinal parasites with nitazoxanide in children in Mexico. American Journal of Tropical Medicine and Hygiene, 68, 384-385.
14. Escobedo, A. A. & Cimerman, S. (2007). Giardiasis: a pharmacotherapy review. Expert Opinion on Pharmacotherapy, 8, 1885-1902.
15. Escobedo, A. A., Núñez, F. A., Moreira, I., Vega, E., Pareja, A. & Almirall, P. (2003). Chloroquine and albendazole in the treatment of paediatric patients with giardiasis. Annals of Tropical Medicine and Parasitology, 97, 367-371.
16. Garcia, L. S. & Bruckner, D. A. (1993). Macroscopic and microscopic examination of fecal specimens. In Diagnostic Medical Parasitology, pp. 501-540. Washington, DC: American Society for Microbiology.
17. Gazder, A. J. & Banerjee, M. (1978). Single dose therapy of giardiasis with tinidazole and metronidazole. Drugs, 15 (Suppl. 1), 30-32.
18. Harris, J. C., Plummer, S. & Lloyd, D. (2001). Antigiardial drugs. Applied Microbiology and Biotechnology, 57, 614-619.
19. Jokipii, A. M. M. & Jokipii, L. (1977). The prepatency of Giardia. Lancet, i, 1095-1097.
20. Manes, G. & Balzano, A. (2004). Tinidazole: from protozoa to Helicobacter pylori-the past, present and future of a nitroimidazole with peculiarities. Expert Review of Anti-infective Therapy, 2, 695-705.
21. Mendoza, D., Núñez, F. A., Escobedo, A. A., Pelayo, L., Fernandez, M., Torres, D. & Cordovi, R. A. (2003). Utilidad de 2 métodos coproparasitológicos y su empleo en un ensayo terapéutico antigiardiasico. Revista Cubana de Medicina Tropical, 55, 174-178.
22. Nash, T. E., Ohl, C. A., Thomas, E., Subramanian, G., Keiser, P. & Moore, T. A. (2001). Treatment of patients with refractory giardiasis. Clinical Infectious Diseases, 33, 22-28.
23. Nigam, P., Kapoor, K. K., Kumar, A., Sarkari, N. B. & Gupta, A. K. (1991). Clinical profile of giardiasis and comparison of its therapeutic response to metronidazole and tinidazole. Journal of the Association of Physicians of India, 39, 613-615.
24. Ortiz, J. J., Ayoub, A. & Gargala, N. L., Chegne, N. L. & Favennec, L. (2001). Randomized clinical study of nitazoxanide compared to metronidazole in the treatment of symptomatic giardiasis in children from the northern Peru. Alimentary Pharmacology and Therapeutics, 15, 1409-1415.
25. Pengsaa, K., Sirivichayakul, C., Pojjaroen-anat, C., Nimnual, S. & Wisetsing, P. (1999). Albendazole treatment for Giardia intestinalis infections in school children. Southeast Asian Journal of Tropical Medicine and Public Health, 30, 78-83.
26. Ponce-Macotela, M., Gómez-Garguño, J., González- Maciel, A., Reynoso-Robles, R., Anislado-Tolentino, V. & Martinez-Gordillo, M. N. (2001). Determinación in vitro de la susceptibilidad a la nitazoxanida de cuatro aislados de Giardia duodenalis obtenidos en diferentes huéspedes. Revista de Investigaciones Clínicas, 53, 41-45.
27. Raether, W. & Hänel, H. (2003). Nitroheterocyclic drugs with broad spectrum activity. Parasitology Research, 90 (Suppl. 1), s19-s39.
28. Rodríguez-García, R., Rodríguez-Guzmán, L. M. & Cruz del Castillo, A. H. (1999). Eficacia y seguridad de mebendazol contra nitazoxanida en el tratamiento de Giardia lamblia en niños. Revista de Gastroenterología Mexicana, 64, 122-126.
29. Romero Cabello, R., Guerrero, L. R., Muñoz Garcia, M. R. & Geyne Cruz, A. (1997). Nitazoxanide for the treatment of intestinal protozoan and helminthic infections in Mexico. Transactions of the Royal Society Tropical Medicine and Hygiene, 91, 701-703.
30. Rossignol, J. F., Ayoub, A. & Ayers, M. S. (2001). Treatment of diarrhea caused by Giardia intestinalis and Entamoeba histolytica or Entamoeba dispar: a randomised, double-blind, placebo-controlled study of metronidazole. Journal of Infectious Diseases, 184, 381-384.
31. Rossignol, J. F., Abu-Zekry, M., Hussein, A. & Santoro, M. G. (2006a). Effect of nitazoxanide for treatment of severe rotavirus diarrhoea: randomised double-blind placebo-controlled trial. Lancet, 368, 124-129.
32. Rossignol, J. F., Kabil, S. M., El-Gohary, Y. & Younis, A. M. (2006b). Effect of nitazoxanide in diarrhoea and enteritis caused by Cryptosporidium species. Clinical Gastroenterology and Hepatology, 4, 320-324.
33. Rossignol, J. F., Kabil, S. M., Said, M., Samir, H. & Younis, A. M. (2006c). Effect of nitazoxanide in persistent diarrhea and enteritis associated with Blastocystis hominis. Clinical Gastroenterology and Hepatology, 3, 987-991.
34. Sanjurjo, G. J. L., Pérez Manauta, J., Hidalgo, L. H. & Geyne, A. (1999). Eficacia y seguridad entre diferentes dosis de nitazoxanida + subcitrato de bismuto + lanzoprazol para la erradicación de Helicobacter pylori. Revista Médica del Hospital General de México, 62, 172-175.
35. Stockis, A., Deroubaix, X., Lins, R., Jeanbaptiste, B., Calderon, P. & Rossignol, J. F. (1996). Pharmacokinetics of nitazoxanide after single oral dose administration in 6 healthy volunteers. International Journal of Clinical Pharmacology and Therapeutics, 34, 349-351
36. Yamamoto, Y., Hakki, A., Friedman, H., Okubo, S., Shimamura, T., Hoffman, P. S. & Rossignol, J. (1999). Nitazoxanide, a nitrothiazolide antiparasitic drug, is an anti-Helicobacter pylori agent with anti-vacuolating toxin activity. Chemotherapy, 45, 303-312.